Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia.

Overview
Research
Identity
Additional Document Info
View All

authors

Roberts, Angela C
Rademaker, Alfred W
Salley, Elizabeth Ann
Mooney, Aimee
Morhardt, Darby
Fried-Oken, Melanie
Weintraub, Sandra
Mesulam, Marsel
Emily Rogalski, PhD

publication date

January 1, 2022

published in

Trials Journal

has subject area